We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
+25.66%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$431M
AUM Growth
+$25.7M
(+6.4%)
Cap. Flow
-$49.3M
Cap. Flow
% of AUM
-11.46%
Top 10 Holdings %
Top 10 Hldgs %
54.85%
Holding
87
New
12
Increased
16
Reduced
29
Closed
10
Top Buys
| 1 |
Biohaven
BHVN
|
+$8.92M |
| 2 |
Procept Biorobotics
PRCT
|
+$3.98M |
| 3 |
HELP
Cybin Inc
HELP
|
+$2.93M |
| 4 |
Denali Therapeutics
DNLI
|
+$2.53M |
| 5 |
MPLT
MapLight Therapeutics
MPLT
|
+$2.41M |
Top Sells
| 1 |
MRUS
Merus
MRUS
|
+$20.8M |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$7.45M |
| 3 |
Axogen
AXGN
|
+$6.53M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$5.59M |
| 5 |
Arcus Biosciences
RCUS
|
+$4M |
Sector Composition
| 1 | Healthcare | 86.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Revolution Medicines
RVMD
$39.2B
| $48.1M | 11.18% |
604,514
-52,662
| -8% | -$3.45M |
|
|
2
State Street SPDR S&P Biotech ETF
XBI
$10.5B
| $41M | 9.53% |
336,505
-65,000
| -16% | -$7.45M |
|
3
Stereotaxis
STXS
$161M
| $31.5M | 7.31% |
13,680,554
| – | – |
|
4
AtriCure
ATRC
$1.76B
| $23.6M | 5.49% |
597,431
+5,158
| +0.9% | +$189K |
|
5
Cytokinetics
CYTK
$11.2B
| $23.6M | 5.48% |
370,997
-23,943
| -6% | -$1.49M |
|
6
IDEAYA Biosciences
IDYA
$3.54B
| $17.5M | 4.07% |
506,740
-33,183
| -6% | -$1.06M |
|
|
7
Axogen
AXGN
$2.07B
| $15.6M | 3.63% |
476,826
-265,456
| -36% | -$6.53M |
|
8
Xenon Pharmaceuticals
XENE
$6.52B
| $12.9M | 3% |
287,939
| – | – |
|
|
9
iShares Biotechnology ETF
IBB
$9.2B
| $11.5M | 2.67% |
68,095
-34,405
| -34% | -$5.59M |
|
|
10
Biohaven
BHVN
$2.23B
| $10.8M | 2.51% |
955,235
+720,000
| +306% | +$8.92M |
|
|
11
Arcus Biosciences
RCUS
$3.52B
| $10.3M | 2.39% |
431,329
-196,297
| -31% | -$4M |
|
12
Neurocrine Biosciences
NBIX
$17.2B
| $10M | 2.33% |
70,615
| – | – |
|
|
DAWN
13
DELISTED
Day One Biopharmaceuticals
DAWN
| $9.31M | 2.16% |
999,163
| – | – |
|
14
Tandem Diabetes Care
TNDM
$1.07B
| $7.81M | 1.81% |
355,208
| – | – |
|
15
Ascendis Pharma A/S
ASND
$17.4B
| $6.01M | 1.4% |
28,177
-5,000
| -15% | -$1.03M |
|
16
DexCom
DXCM
$28.6B
| $5.86M | 1.36% |
88,279
+22,727
| +35% | +$1.47M |
|
17
Syndax Pharmaceuticals
SNDX
$2.12B
| $5.84M | 1.36% |
277,855
-222,847
| -45% | -$3.89M |
|
|
KALV
18
DELISTED
KalVista Pharmaceuticals
KALV
| $5.76M | 1.34% |
356,802
-65,929
| -16% | -$873K |
|
|
CMPS
19
Compass Pathways
CMPS
$1.75B
| $5.6M | 1.3% |
811,046
| – | – |
|
20
Inogen
INGN
$172M
| $5.56M | 1.29% |
827,071
+221,446
| +37% | +$1.66M |
|
|
21
Denali Therapeutics
DNLI
$3.61B
| $5.26M | 1.22% |
318,500
+150,000
| +89% | +$2.53M |
|
|
MBX
22
MBX Biosciences
MBX
$2.79B
| $5.21M | 1.21% |
165,265
+80,265
| +94% | +$1.95M |
|
|
BCAX
23
Bicara Therapeutics
BCAX
$1.83B
| $4.4M | 1.02% |
261,583
-55,418
| -17% | -$946K |
|
|
LKFT
24
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| $4.26M | 0.99% |
130,175
| – | – |
|
|
ATXS
25
DELISTED
Astria Therapeutics
ATXS
| $3.99M | 0.93% |
304,775
-15,000
| -5% | -$179K |
|
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML